Ahk-Cu

Overview

AHK-Cu (L-alanyl-L-histidyl-L-lysine-copper complex) is a copper-bound tripeptide that acts as a growth factor for differentiated cells. It drives dermal fibroblast proliferation, increases vascular endothelial growth factor production, and has been studied mostly for its effects on hair-follicle growth and dermal papilla cell function. Like other peptides, it is generally sold as a research chemical, so purity and storage matter.

Editorial verdict

This is a compound with an appealing cosmetic premise and almost no evidence behind it. A single in vitro study underpins the entire profile. The lab signal for hair growth is real but extremely preliminary, and there is no human trial data, no established topical concentration, and no proven real-world benefit. Anyone buying AHK-Cu for hair loss is essentially running their own uncontrolled experiment.

Evidence quality

We rate the research C−, weighted across just 1 peer-reviewed study (1 in vitro). That single classified finding was supporting. The human evidence base has no RCTs or meta-analyses on file. This is about as thin as an evidence base gets.

What research shows

In the one available study, AHK-Cu at concentrations of 10⁻¹² to 10⁻⁹ M stimulated elongation of human hair follicles and proliferation of dermal papilla cells. It also reduced apoptosis markers, raising the Bcl-2/Bax ratio and lowering cleaved caspase-3 levels. These are encouraging cell-level findings, but they were generated ex vivo and have not been confirmed in living people.

Who should be cautious

Because there is no long-term human data and no standardized topical formulation, anyone with sensitive skin or scalp conditions should be careful. Copper-peptide preparations also vary widely in quality, and there is no agreed-upon delivery method.

Community sentiment

Community feedback is sparse: across 20 reports, sentiment was logged as 100% neutral, with no clearly positive or negative tally. The most mentioned effect was hair-follicle stimulation; a lone report mentioned a painful injection.

Dosage

Research used 10⁻¹² to 10⁻⁹ M, with 10⁻⁹ M optimal. Users looking to build topical serums have no established protocol to follow. It is intended for topical scalp use, but consumer-level concentration guidance is missing, and no dosing schedule exists in available reports.

Effectiveness and availability

AHK-Cu is active at very low concentrations in the lab and showed positive effects on follicle growth in ex vivo testing, but minimal human reports exist to confirm topical effectiveness, and optimal delivery is unclear. It can be bought as a research peptide, yet few commercial formulations exist. Many users try to mix their own serums for lack of ready-made products, and it is not a common ingredient in mainstream hair-care or supplement lines.